Seelos Therapeutics Inc (SEEL) News

SEEL new 52 lo

Down 31%. Close $0.6279. WTH.

SEEL 10Q due March 12

Pretty sad.

SEEL new 52 week low

SELL Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
https://www.prnewswire.com/news-releases/seelos-therapeutics-inc-announces-4-0-million-registered-direct-offering-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules-302045669.html

8-K https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/93010517/form-8-k-current-report

Form 4 https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92986476/form-4-statement-of-changes-in-beneficial-owners

I voted No to Proxy. More dilution planned and increase in outstanding shares.

$1.66, up 7%.

“Thank you”

You are a master of two word messages all over Ihub.

back to DUMPING I see

Form 4 https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92705677/form-4-statement-of-changes-in-beneficial-owners

PRE-14A https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92718397/form-pre-14a-other-preliminary-proxy-statements

Close $1.96, up 42%.

RELENTESS BUYING. HOD $2.17.

$1.35, UP. RELENTLESS BUYING.

8-K

https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92695438/form-8-k-current-report

INCONTROVERTIBLE DUMPING

Form 424B5 - Prospectus [Rule 424(b)(5)]

https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/92670943/form-424b5-prospectus-rule-424b5

CONSTANT “DUMPING” by 👇👇👇

https://investorshub.advfn.com/boards/profile.aspx?user=114150

ANNOYING DUMPING

What an annoying asshole

INDEFATIGABLE SELLING

RELENTLESS DUMPING

RS 1:30 tomorrow. I’m holding. Never know if good news is released.

UNYIELDING DUMPING

Seelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)

PUBLISHED
NOV 27, 2023 8:00AM EST

https://www.nasdaq.com/press-release/seelos-therapeutics-announces-the-selection-of-sls-002-intranasal-racemic-ketamine

News out.

SEEL will retain it’s Nasdaq standing.

11.03.2023 8-K Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On November 1, 2023, Seelos Therapeutics, Inc. (the “Company”) received written notice (the “First Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until April 29, 2024, to regain compliance. The First Notice states that the Nasdaq staff will provide written confirmation that the Company has achieved compliance with Rule 5550(a)(2) if at any time before April 29, 2024, the bid price of the Company’s common stock closes at $1.00 per share or more for a minimum of ten consecutive business days.

lod $0.1065.

Wow, $0.139.

SLS-005 ALS results due by year end

Any possible catalyst here?

About ready to avg. down but waiting for a dip to .17 area.

.199 now.

SEEL.....from .1651 to .2020 in 4 days is good enough for me

Headed back towards .5

In

SEEL, and TVTX are my bounce plays for next week. My SEEL pps average is around .1651

Bottoms in

Looks to be artificially took down with 3 days of more buying then selling

Phase 2 failed and next day dilution. One two punch.

8-K https://www.advfn.com/stock-market/NASDAQ/SEEL/stock-news/92084983/form-8-k-current-report

Damn. Bad news I guess

Up 12.5%. $1.26 close.

one more thing : my other message is for 29 december.

invest in seel for another 9 months, be patient and you will say :
super and easy investment/share

Seelos Therapeutics Receives a Research and Development Grant from The Michael J. Fox Foundation for Parkinson's Research for SLS-004

https://stocks.apple.com/AM7QB43SnTqKq3XVata-xyA